The network map of mucin 1 mediated signaling in cancer progression and immune modulation
Abstract Mucin 1 (MUC1) is a type-I transmembrane glycoprotein, ranked as the second most promising cancer antigen for therapeutic development by the National Cancer Institute. Recently, MUC1 has gained significant attention as a therapeutic target in cancer immunotherapy. Thus, understanding MUC1-r...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03030-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849234800961912832 |
|---|---|
| author | Akhina Palollathil Shobha Dagamajalu Mukhtar Ahmed Manavalan Vijayakumar Thottethodi Subrahmanya Keshava Prasad Rajesh Raju |
| author_facet | Akhina Palollathil Shobha Dagamajalu Mukhtar Ahmed Manavalan Vijayakumar Thottethodi Subrahmanya Keshava Prasad Rajesh Raju |
| author_sort | Akhina Palollathil |
| collection | DOAJ |
| description | Abstract Mucin 1 (MUC1) is a type-I transmembrane glycoprotein, ranked as the second most promising cancer antigen for therapeutic development by the National Cancer Institute. Recently, MUC1 has gained significant attention as a therapeutic target in cancer immunotherapy. Thus, understanding MUC1-regulated signaling is essential for advancing therapeutic strategies. Since existing pathway repositories lack a comprehensive MUC1 signaling map, we constructed one by manually annotating experimentally validated signaling events from 115 articles following NetPath annotation criteria. Considering the topology of annotated molecules, a pathway map was developed using the PathVisio software. This pathway map is a valuable resource cataloguing 209 molecules and 690 signaling events, of which 395 events are unique. The catalogued reactions include 118 enzyme catalysis events, 133 molecular associations, 132 gene regulation events, 216 protein expressions, 49 activation/inhibition and 42 protein translocation events. MUC1 signaling pathway showed significant cross-talk with Wnt/β-catenin, NF-κB, PI3K-AKT, and MAPK signaling. The aberrant expression of MUC1 is associated with proliferation, metastasis, angiogenesis and invasion in various cancers, such as breast, lung, pancreatic, colon, oral, prostate, ovarian, and gastric cancers. Moreover, it also regulates the proliferation and function of immune cells, including myeloid-derived suppressor cells, tumour-associated macrophages, dendritic cells, CD4 + T-cells and CD8 + T-cells. This pathway map may serve as a valuable reference for understanding MUC1-driven oncogenic and immunomodulatory mechanisms, providing insights for developing novel therapeutic strategies for cancer treatment. |
| format | Article |
| id | doaj-art-c4822a3121aa4eecbb06b976f040fd60 |
| institution | Kabale University |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-c4822a3121aa4eecbb06b976f040fd602025-08-20T04:03:01ZengSpringerDiscover Oncology2730-60112025-07-0116111510.1007/s12672-025-03030-zThe network map of mucin 1 mediated signaling in cancer progression and immune modulationAkhina Palollathil0Shobha Dagamajalu1Mukhtar Ahmed2Manavalan Vijayakumar3Thottethodi Subrahmanya Keshava Prasad4Rajesh Raju5Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University)Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University)Department of Zoology, College of Science, King Saud UniversityDepartment of Surgical Oncology, Yenepoya Medical College, Yenepoya (Deemed to Be University)Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University)Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University)Abstract Mucin 1 (MUC1) is a type-I transmembrane glycoprotein, ranked as the second most promising cancer antigen for therapeutic development by the National Cancer Institute. Recently, MUC1 has gained significant attention as a therapeutic target in cancer immunotherapy. Thus, understanding MUC1-regulated signaling is essential for advancing therapeutic strategies. Since existing pathway repositories lack a comprehensive MUC1 signaling map, we constructed one by manually annotating experimentally validated signaling events from 115 articles following NetPath annotation criteria. Considering the topology of annotated molecules, a pathway map was developed using the PathVisio software. This pathway map is a valuable resource cataloguing 209 molecules and 690 signaling events, of which 395 events are unique. The catalogued reactions include 118 enzyme catalysis events, 133 molecular associations, 132 gene regulation events, 216 protein expressions, 49 activation/inhibition and 42 protein translocation events. MUC1 signaling pathway showed significant cross-talk with Wnt/β-catenin, NF-κB, PI3K-AKT, and MAPK signaling. The aberrant expression of MUC1 is associated with proliferation, metastasis, angiogenesis and invasion in various cancers, such as breast, lung, pancreatic, colon, oral, prostate, ovarian, and gastric cancers. Moreover, it also regulates the proliferation and function of immune cells, including myeloid-derived suppressor cells, tumour-associated macrophages, dendritic cells, CD4 + T-cells and CD8 + T-cells. This pathway map may serve as a valuable reference for understanding MUC1-driven oncogenic and immunomodulatory mechanisms, providing insights for developing novel therapeutic strategies for cancer treatment.https://doi.org/10.1007/s12672-025-03030-zCancerSignaling pathwayImmunotherapyImmunosuppressionImmune evasion |
| spellingShingle | Akhina Palollathil Shobha Dagamajalu Mukhtar Ahmed Manavalan Vijayakumar Thottethodi Subrahmanya Keshava Prasad Rajesh Raju The network map of mucin 1 mediated signaling in cancer progression and immune modulation Discover Oncology Cancer Signaling pathway Immunotherapy Immunosuppression Immune evasion |
| title | The network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| title_full | The network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| title_fullStr | The network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| title_full_unstemmed | The network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| title_short | The network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| title_sort | network map of mucin 1 mediated signaling in cancer progression and immune modulation |
| topic | Cancer Signaling pathway Immunotherapy Immunosuppression Immune evasion |
| url | https://doi.org/10.1007/s12672-025-03030-z |
| work_keys_str_mv | AT akhinapalollathil thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT shobhadagamajalu thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT mukhtarahmed thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT manavalanvijayakumar thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT thottethodisubrahmanyakeshavaprasad thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT rajeshraju thenetworkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT akhinapalollathil networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT shobhadagamajalu networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT mukhtarahmed networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT manavalanvijayakumar networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT thottethodisubrahmanyakeshavaprasad networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation AT rajeshraju networkmapofmucin1mediatedsignalingincancerprogressionandimmunemodulation |